80 results
Page 3 of 4
8-K
EX-10.2
wiz1m8
6 Jan 21
Ameri Holdings Announces 1-FOR-4 Reverse Stock Split
5:10pm
8-K
EX-3.3
g8tw5cm0j53x6a88ce
6 Jan 21
Ameri Holdings Announces 1-FOR-4 Reverse Stock Split
5:10pm
8-K
EX-10.3
7dybpswnxzv3 5mp
6 Jan 21
Ameri Holdings Announces 1-FOR-4 Reverse Stock Split
5:10pm
8-K
EX-10.1
3qhtsx8
6 Jan 21
Ameri Holdings Announces 1-FOR-4 Reverse Stock Split
5:10pm
S-4MEF
EX-8.2
ot8cqyzn1zqu7f9rvx
28 Dec 20
Addition of securities to prior registration
5:30pm
S-4MEF
EX-8.1
9o45yv
28 Dec 20
Addition of securities to prior registration
5:30pm
8-K
EX-10.1
uvpsshov5bq0uo
11 Sep 20
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.2
r4zw 0gjk08p9y0
11 Sep 20
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.1
c7kzbx9zx84ivd19rirj
12 Aug 20
Entry into a Material Definitive Agreement
5:19pm
8-K
EX-10.1
3r7cdhn
3 Aug 20
Entry into a Material Definitive Agreement
8:00am
8-K
EX-4.1
35wy9gauuq 165
3 Aug 20
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.3
itjspnsds0rji 15bn
4 Jun 20
Ameri Holdings Amalgamation Partner Jay Pharma Reports Irb Approval for Testing Proprietary CBD Formulation In Brain Cancer
9:00am
8-K
EX-10.1
o0k5cedodjg rhssk
4 Jun 20
Ameri Holdings Amalgamation Partner Jay Pharma Reports Irb Approval for Testing Proprietary CBD Formulation In Brain Cancer
9:00am
8-K
EX-10.2
79anc p997m1i9
4 Jun 20
Ameri Holdings Amalgamation Partner Jay Pharma Reports Irb Approval for Testing Proprietary CBD Formulation In Brain Cancer
9:00am